Asom
Asom
Asom
Dr H P Singh
Additional Professor
Disclaimer
➢Stage of presuppuration
➢Stage of suppuration
deafness/ earache
➢Stage of presuppuration
if occlusion prolonged
inflammatory exudate /
suppuration
high grade fever/restless
cart wheel appearance
Stage of suppuration
pus formation
point of rupture: nipple like pron
TM bulges
fever / convulsion
mastoid tenderness
➢Stage of resolution/ complication
Partial resolution
Complete resolution
ACUTE NECROTISING OTITIS
MEDIA
• It is a variety of acute suppurative otitis media, often seen in children
suffering from measles, scarlet fever or influenza.
►Post-AOM
►Most episodes resolve spontaneously within 3
months
►30%-40% Recurrent OME
►5%-10% Persistent OME > 1 year
►Clinicians should use pneumatic otoscopy as the primary
diagnostic method for OME. OME should be
distinguished from AOM.
►Strong recommendation
– Pneumatic otoscopy is gold standard
►Color
►Position
►Mobility
►Tympanic membrane appearance
– Sensitivity of 94% and specificity of 80% versus myringotomy
– Readily available, cost effective and accurate in experienced
hands
►Tympanometry can be used to confirm
diagnosis.
– When diagnosis is uncertain, consider
tympanometry
►Cost associated with equipment
►Painless
►Reliable for ages 4 months or older
► Population-based screening programs for OME are not
recommended in healthy, asymptomatic children.
► Highly prevalent in young children. 15%-40% point prevalence in
healthy children under 5 yr
– No influence on short-term language outcomes
– No benefit from treatment that exceeds the favorable natural
history of the disease
– Risk of inaccurate diagnoses, overtreatment, parental
anxiety, and increased cost
►Clinicians should document the laterality,
duration of effusion, and presence and
severity of associated symptoms at each
assessment of the child with OME.
Recommendation
– Medical decision making depends on these
features
– 40%-50% of OME cases no symptoms
– Preponderance of benefit over harm
► Clinicians should distinguish the child with OME who is at risk for speech,
language, or learning problems from other children with OME, and should
more promptly evaluate hearing, speech, language, and need for
intervention.
– Permanent hearing loss
– Speech and language delay or disorder
– Autism-spectrum disorder/PDD
– Syndromes with cognitive, speech, and language delays
– Blindness
– Cleft Palate
– Developmental delay
►Clinicians should manage the child with OME who is
not at risk with watchful waiting for 3 months from the
date effusion onset (if known) or from the date of
diagnosis (if onset is unknown).
– OME is usually self-limited
– 75%-90% of OME after AOM resolves spontaneously
by 3 months
– Waiting results in little harm to child
– Optimize listening and learning environment until
effusion resolves
►Antihistamines and decongestants are
ineffective for OME and are not recommended
for treatment.
►Antimicrobials and corticosteroids do no have
long-term efficacy and are not recommended
for routine management.
– Short-term, small magnitude benefits
– Significant adverse effects
►Hearing testing is recommended when OME
persists for 3 months or longer, or at any time
that language delay, learning problems, or a
significant hearing loss is suspected in a child
with OME. Language testing should be
conducted for children with hearing loss.
►HL may impair early language acquisition
►Extended periods of CHL may result in
developmental and academic sequelae
►Early language delays are associated with
later delays in reading and writing.
► Children with persistent OME who are not at risk should be
reexamined at 3- to 6-month intervals until the effusion is no
longer present, significant hearing loss is identified, or
structural abnormalities of the TM or middle ear are
suspected.
– Resolution rates decrease the longer the effusion has been present
– Risk factors for non-resolution:
►Summer or fall onset
►HL>30dB
►H/O prior tympanostomy tubes
►Not having had an adenoidectomy
►When a child becomes a surgical candidate,
tympanostomy tube insertion is the preferred
initial procedure; adenoidectomy should not
be performed unless a distinct indication
exists (nasal obstruction, chronic adenoiditis).
Repeat surgery consists of adenoidectomy
plus myringotomy, with or without tube
insertion. Tonsillectomy alone or myringotomy
alone should not be used to treat OME.
►OME > 4 months with persistent hearing loss
►Recurrent or persistent OME in at risk child
►OME with structural damage to TM or ME
Consequences
►Inappropriate antibiotic treatment of OM
– Multidrug-resistant strains
– Drug side effects
– Parental/caregiver confusion
Recurrent Acute Otitis Media